skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: ClinicalKey remover assunto: Male remover Leukopenia remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial
Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial

Johnston, Stephen R D ; Toi, Masakazu ; O'Shaughnessy, Joyce ; Rastogi, Priya ; Campone, Mario ; Neven, Patrick ; Huang, Chiun-Sheng ; Huober, Jens ; Jaliffe, Georgina Garnica ; Cicin, Irfan ; Tolaney, Sara M ; Goetz, Matthew P ; Rugo, Hope S ; Senkus, Elzbieta ; Testa, Laura ; Del Mastro, Lucia ; Shimizu, Chikako ; Wei, Ran ; Shahir, Ashwin ; Munoz, Maria ; San Antonio, Belen ; André, Valérie ; Harbeck, Nadia ; Martin, Miguel

The lancet oncology, 2023-01, Vol.24 (1), p.77-90 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study
Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study

Qiu, Haiyan ; Wu, Junhua ; Hong, Liang ; Luo, Yunling ; Song, Qifa ; Chen, Dong

The Lancet infectious diseases, 2020-06, Vol.20 (6), p.689-696 [Periódico revisado por pares]

United States: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials
Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials

Fang, Wenfeng ; Yang, Yunpeng ; Ma, Yuxiang ; Hong, Shaodong ; Lin, Lizhu ; He, Xiaohui ; Xiong, Jianping ; Li, Ping ; Zhao, Hongyun ; Huang, Yan ; Zhang, Yang ; Chen, Likun ; Zhou, Ningning ; Zhao, Yuanyuan ; Hou, Xue ; Yang, Qing ; Zhang, Li

The lancet oncology, 2018-10, Vol.19 (10), p.1338-1350 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study
Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study

Barlesi, Fabrice ; Vansteenkiste, Johan ; Spigel, David ; Ishii, Hidenobu ; Garassino, Marina ; de Marinis, Filippo ; Özgüroğlu, Mustafa ; Szczesna, Aleksandra ; Polychronis, Andreas ; Uslu, Ruchan ; Krzakowski, Maciej ; Lee, Jong-Seok ; Calabrò, Luana ; Arén Frontera, Osvaldo ; Ellers-Lenz, Barbara ; Bajars, Marcis ; Ruisi, Mary ; Park, Keunchil

The lancet oncology, 2018-11, Vol.19 (11), p.1468-1479 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study
Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study

Zhong, Wen-Zhao ; Wang, Qun ; Mao, Wei-Min ; Xu, Song-Tao ; Wu, Lin ; Shen, Yi ; Liu, Yong-Yu ; Chen, Chun ; Cheng, Ying ; Xu, Lin ; Wang, Jun ; Fei, Ke ; Li, Xiao-Fei ; Li, Jian ; Huang, Cheng ; Liu, Zhi-Dong ; Xu, Shun ; Chen, Ke-Neng ; Xu, Shi-Dong ; Liu, Lun-Xu ; Yu, Ping ; Wang, Bu-Hai ; Ma, Hai-Tao ; Yan, Hong-Hong ; Yang, Xue-Ning ; Zhou, Qing ; Wu, Yi-Long ; Wu, Yi-Long ; Wang, Qun ; Mao, Wei-Min ; Wu, Lin ; Shen, Yi ; Liu, Yong-Yu ; Chen, Chun ; Cheng, Ying ; Xu, Lin ; Wang, Jun ; Fei, Ke ; Li, Xiao-Fei ; Li, Jian ; Huang, Cheng ; Liu, Zhi-Dong ; Xu, Shun ; Chen, Ke-Neng ; Xu, Shi-Dong ; Liu, Lun-Xu ; Yu, Ping ; Wang, Bu-Hai ; Ma, Hai-Tao ; Wang, Si-Yu ; Hu, Jian ; Liu, Wei ; Li, Wei ; Shi, Jian-Hua

The lancet oncology, 2018-01, Vol.19 (1), p.139-148 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study
Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study

Laetsch, Theodore W ; DuBois, Steven G ; Mascarenhas, Leo ; Turpin, Brian ; Federman, Noah ; Albert, Catherine M ; Nagasubramanian, Ramamoorthy ; Davis, Jessica L ; Rudzinski, Erin ; Feraco, Angela M ; Tuch, Brian B ; Ebata, Kevin T ; Reynolds, Mark ; Smith, Steven ; Cruickshank, Scott ; Cox, Michael C ; Pappo, Alberto S ; Hawkins, Douglas S

The lancet oncology, 2018-05, Vol.19 (5), p.705-714 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
Repeated blood–brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trial
Repeated blood–brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Repeated blood–brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trial

Sonabend, Adam M ; Gould, Andrew ; Amidei, Christina ; Ward, Rachel ; Schmidt, Karyn A ; Zhang, Daniel Y ; Gomez, Cristal ; Bebawy, John F ; Liu, Benjamin P ; Bouchoux, Guillaume ; Desseaux, Carole ; Helenowski, Irene B ; Lukas, Rimas V ; Dixit, Karan ; Kumthekar, Priya ; Arrieta, Víctor A ; Lesniak, Maciej S ; Carpentier, Alexandre ; Zhang, Hui ; Muzzio, Miguel ; Canney, Michael ; Stupp, Roger

The lancet oncology, 2023-05, Vol.24 (5), p.509-522 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial
Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial

Bisogno, Gianni ; De Salvo, Gian Luca ; Bergeron, Christophe ; Gallego Melcón, Soledad ; Merks, Johannes H ; Kelsey, Anna ; Martelli, Helene ; Minard-Colin, Veronique ; Orbach, Daniel ; Glosli, Heidi ; Chisholm, Julia ; Casanova, Michela ; Zanetti, Ilaria ; Devalck, Christine ; Ben-Arush, Myriam ; Mudry, Peter ; Ferman, Sima ; Jenney, Meriel ; Ferrari, Andrea

The lancet oncology, 2019-11, Vol.20 (11), p.1566-1575 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial
Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial

Bisogno, Gianni ; Jenney, Meriel ; Bergeron, Christophe ; Gallego Melcón, Soledad ; Ferrari, Andrea ; Oberlin, Odile ; Carli, Modesto ; Stevens, Michael ; Kelsey, Anna ; De Paoli, Angela ; Gaze, Mark N ; Martelli, Helene ; Devalck, Christine ; Merks, Johannes H ; Ben-Arush, Myriam ; Glosli, Heidi ; Chisholm, Julia ; Orbach, Daniel ; Minard-Colin, Veronique ; De Salvo, Gian Luca ; Cesen, Maja ; Rose, Adriana ; Ferman, Sima ; Mudry, Peter ; Sejnova, Daniela ; Dal Bianco, Paola ; Zanetti, Ilaria ; Niggli, Felix ; Rogers, Timothy ; Cecchetto, Giovanni ; De Corti, Federica ; Guerin, Florent ; Terwisscha, Sheila ; Ranchere, Dominique ; Alaggio, Rita ; Shipley, Janet ; Rosolen, Angelo ; Mandeville, Henry ; Scarzello, Giovanni ; Bernier, Valerie ; McHugh, Kieran

The lancet oncology, 2018-08, Vol.19 (8), p.1061-1071 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
10
Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial
Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial

Tap, William D ; Papai, Zsuzsanna ; Van Tine, Brian A ; Attia, Steven ; Ganjoo, Kristen N ; Jones, Robin L ; Schuetze, Scott ; Reed, Damon ; Chawla, Sant P ; Riedel, Richard F ; Krarup-Hansen, Anders ; Toulmonde, Maud ; Ray-Coquard, Isabelle ; Hohenberger, Peter ; Grignani, Giovanni ; Cranmer, Lee D ; Okuno, Scott ; Agulnik, Mark ; Read, William ; Ryan, Christopher W ; Alcindor, Thierry ; del Muro, Xavier F Garcia ; Budd, G Thomas ; Tawbi, Hussein ; Pearce, Tillman ; Kroll, Stew ; Reinke, Denise K ; Schöffski, Patrick

The lancet oncology, 2017-08, Vol.18 (8), p.1089-1103 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (104)

Data de Publicação 

De até
Refinar
  1. Antes de1994  (10)
  2. 1994Até2001  (11)
  3. 2002Até2008  (16)
  4. 2009Até2015  (24)
  5. Após 2015  (45)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.